Indication

Lichen simplex chronicus

Lichen simplex chronicus is a chronic localized neurodermatitis of the integumentary system that develops secondary to repeated, habitual scratching or rubbing. Read more about Lichen simplex chronicus

739 drugs 194 manufacturers

Advertisement

Drugs that treat it

Common Lichen simplex chronicus therapies.

Showing 397–405 of 739 drugs

FLUOCINONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
E Fougera

DESONIDE

PYODERMA GANGRENOSUM·+13
L Perrigo Company

DESONIDE

TOPICAL CORTICOSTEROIDS·PYODERMA GANGRENOSUM·+13
Actavis Pharma

DESONIDE

PYODERMA GANGRENOSUM·+13
L Perrigo Company
Filter & compare in the drug finder →Opens the drug finder with Lichen simplex chronicus preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Lichen simplex chronicus.

Lichen simplex chronicus is a chronic localized neurodermatitis of the integumentary system that develops secondary to repeated, habitual scratching or rubbing.

It predominantly affects adults, particularly individuals with an underlying history of atopic diathesis, pre-existing pruritic dermatoses, or psychological stress and anxiety disorders.

Driven by a self-perpetuating itch-scratch cycle, the condition is clinically and pathophysiologically characterized by well-demarcated, intensely pruritic, thickened plaques displaying cutaneous lichenification, hyperkeratosis, acanthosis, and exaggerated skin markings on accessible body regions.

Personalize your experience

Follow Lichen simplex chronicus and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it